Research Centre’s Activities
In addition to the funding opportunities announced on the investment page, below is a list of other activities undertaken by the CRPPHE team and collaborators in support of delivering on the Center’s mandate.
2023
- Solidarity Ebola: Vaccine Trial Against Sudan Ebolavirus
In partnership with the Public Health Agency of Canada (PHAC) and the International Development Research Center (IDRC) the CRPPHE invested $1.5M as part of Canada’s total $4.8 M contribution to support a 2-year study on the safety and immunogenicity of three candidate vaccines against Ebola disease caused by Sudan ebolavirus; build national clinical trial capabilities to respond to future outbreaks; and strengthen local and global research and development capabilities for clinical research on vaccines for priority diseases. - Canadian Post COVID-19 Condition Research Network Kick-off Meeting
Shortly after announcing the results of the $20 million Post COVID-19 Condition (PCC) Research Network grant competition, the CRPPHE held a kick-off meeting on February 6, 2023, to introduce the successful team to key Government of Canada departments and initiatives relevant to the Post COVID-19 condition. This meeting had the overall objective of enabling and facilitating coordination and cohesion between ongoing Government of Canada initiatives relevant to addressing the long-term biological, clinical and population impacts of COVID-19 infections on people living in Canada and Canadian health systems. This funded network and coordination efforts are also in alignment with the recommendations that were identified by the Chief Science Advisor’s Task Force on Post-COVID-19 condition.
- Date modified: